Kevin Lobo to leave Parker-Hannifin (PH) board after 2026 meeting

Q: What board change did Parker-Hannifin (PH) disclose on March 13, 2026?

Parker-Hannifin disclosed that Director Kevin A. Lobo will not stand for reelection at the company’s 2026 Annual Meeting of Shareholders. He has served as a Director since 2013 and will remain on the Board until his current term expires.

Q: Is Kevin A. Lobo leaving Parker-Hannifin’s Board immediately?

No. The filing states that Kevin A. Lobo is expected to continue serving as a Director until the expiration of his current term, which runs through the 2026 Annual Meeting of Shareholders, even though he will not stand for reelection.

Q: Did Kevin A. Lobo’s decision involve a disagreement with Parker-Hannifin (PH)?

No. The company states that Mr. Lobo’s decision not to stand for reelection was not the result of any disagreement with Parker-Hannifin relating to its operations, policies, or practices, suggesting a routine governance change rather than a contentious departure.

Q: How long has Kevin A. Lobo served on Parker-Hannifin’s Board of Directors?

Kevin A. Lobo has served as a Director of Parker-Hannifin since 2013. The filing highlights this tenure as part of the context for his decision not to stand for reelection at the 2026 Annual Meeting of Shareholders.

Q: Who signed the Parker-Hannifin 8-K reporting the board change?

The report was signed on behalf of Parker-Hannifin Corporation by Joseph R. Leonti, who is identified as Executive Vice President, General Counsel and Secretary. His signature confirms the company’s authorization of the disclosed board change information.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Parker-Hannifin Corporation reported that Director Kevin A. Lobo has informed the company he will not stand for reelection to its Board of Directors at the 2026 Annual Meeting of Shareholders. He has served on the board since 2013 and plans to serve through the end of his current term.

Lobo noted that his decision is due to his election to the Board of Directors of GE HealthCare Technologies Inc. The company stated that his decision is not the result of any disagreement with Parker-Hannifin regarding its operations, policies or practices, indicating a routine board transition.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Understanding 8-K Material Events →

03/17/2026 - 04:10 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): March 13, 2026

PARKER-HANNIFIN CORPORATION

(Exact Name of Registrant as Specified in Charter)

Ohio

1-4982

34-0451060

(State or other jurisdiction of

Incorporation or Organization)

(Commission

File Number)

(I.R.S. Employer

Identification No.)


6035 Parkland Boulevard, Cleveland, Ohio		44124-4141
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (216) 896-3000

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading
Symbol

Name of Each Exchange

on which Registered

Common Shares, $.50 par value

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 13, 2026, Kevin A. Lobo notified Parker-Hannifin Corporation (the “Company”) that he will not stand for reelection to the Company’s Board of Directors at the Company’s 2026 Annual Meeting of Shareholders. Mr. Lobo has served as a Director of the Company since 2013. He noted that his decision not to stand for reelection is a result of his election to the Board of Directors of GE HealthCare Technologies Inc. Mr. Lobo’s decision not to stand for reelection was not a result of any disagreement with the Company relating to the Company’s operations, policies or practices. Mr. Lobo is expected to continue to serve as a Director of the Company until the expiration of his current term.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.


		PARKER-HANNIFIN CORPORATION

	By:	/s/ Joseph R. Leonti
		Joseph R. Leonti
		Executive Vice President, General Counsel and Secretary

Date: March 17, 2026

Source: View Original Filing on SEC EDGAR

FAQ

What board change did Parker-Hannifin (PH) disclose on March 13, 2026?

Parker-Hannifin disclosed that Director Kevin A. Lobo will not stand for reelection at the company’s 2026 Annual Meeting of Shareholders. He has served as a Director since 2013 and will remain on the Board until his current term expires.

Why is Parker-Hannifin Director Kevin A. Lobo not standing for reelection?

Kevin A. Lobo decided not to stand for reelection because of his election to the Board of Directors of GE HealthCare Technologies Inc. The filing explains this new board role as the reason for his decision regarding Parker-Hannifin’s Board.

Is Kevin A. Lobo leaving Parker-Hannifin’s Board immediately?

No. The filing states that Kevin A. Lobo is expected to continue serving as a Director until the expiration of his current term, which runs through the 2026 Annual Meeting of Shareholders, even though he will not stand for reelection.

Did Kevin A. Lobo’s decision involve a disagreement with Parker-Hannifin (PH)?

No. The company states that Mr. Lobo’s decision not to stand for reelection was not the result of any disagreement with Parker-Hannifin relating to its operations, policies, or practices, suggesting a routine governance change rather than a contentious departure.

How long has Kevin A. Lobo served on Parker-Hannifin’s Board of Directors?

Kevin A. Lobo has served as a Director of Parker-Hannifin since 2013. The filing highlights this tenure as part of the context for his decision not to stand for reelection at the 2026 Annual Meeting of Shareholders.

Who signed the Parker-Hannifin 8-K reporting the board change?

The report was signed on behalf of Parker-Hannifin Corporation by Joseph R. Leonti, who is identified as Executive Vice President, General Counsel and Secretary. His signature confirms the company’s authorization of the disclosed board change information.

Filing Exhibits & Attachments

3 documents